Dorlo, T. P. C.; Balasegaram, M.; Beijnen, J. H.; De Vries, P. J. (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis". The Journal of Antimicrobial Chemotherapy. 67 (11): 2576–97. doi:10.1093/jac/dks275. PMID22833634.
Minodier, P; Parola, P (May 2007). "Cutaneous leishmaniasis treatment". Travel Medicine and Infectious Disease. 5 (3): 150–8. doi:10.1016/j.tmaid.2006.09.004. PMID17448941.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert Review of Anti-infective Therapy. 11 (1): 79–98. doi:10.1586/eri.12.148. PMID23428104. S2CID20508342.
Dorlo, T. P. C.; Balasegaram, M.; Beijnen, J. H.; De Vries, P. J. (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis". The Journal of Antimicrobial Chemotherapy. 67 (11): 2576–97. doi:10.1093/jac/dks275. PMID22833634.
Minodier, P; Parola, P (May 2007). "Cutaneous leishmaniasis treatment". Travel Medicine and Infectious Disease. 5 (3): 150–8. doi:10.1016/j.tmaid.2006.09.004. PMID17448941.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert Review of Anti-infective Therapy. 11 (1): 79–98. doi:10.1586/eri.12.148. PMID23428104. S2CID20508342.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert Review of Anti-infective Therapy. 11 (1): 79–98. doi:10.1586/eri.12.148. PMID23428104. S2CID20508342.